1. Guidance for Presenters
2. Guidance for Panelists
3. Schedule of Panels

A. Guidance for Presenters (see How to Prepare for a Panel for further advice)

• Where and When: See Schedule
  Presenters should be in the room at least 5 minutes before the time of their panel. Non-presenters (and panelists) are welcome at any time.
   
• Duration of presentation: Up to seven minutes and no more. At six minutes, you'll hear a courteous tinkle of a bell. At seven minutes, a bone-shaking clang will stop your presentation if it has not already concluded. If you're in the middle of a sentence, you'll be permitted to complete the sentence (with no more than one conjunction), but that's it.
   
• Duration of question and answer period: Up to eight minutes, marked by a bell. Questions will be posed by the panel concerning the presentation and the written proposal.
   
• Loading presentations: There won't be time to download your presentation. It must be on the computer before the panels begin. This can be done in either of two ways:
   
  • E-mail your presentation to me by 15 minutes before the beginning of the panel
  • Bring your presentation on a memory device by 15 minutes before the beginning of the panel
  
  Do not expect to download it from your e-mail or upload it on the spot from your memory device.
   

B. Guidance for Panelists

• Reviewers: Each proposal has been assigned a primary reviewer and a secondary reviewer, noted in the schedule. The primary reviewer will begin the discussion after the presentation. All panelists are invited, nay, urged to join in as well.
   
• Goals of the proposal: Please see How to Write a Research Proposal to see the goals presenters were asked to address. If you like, you can also take a look at an example of a proposal.
   
• Goals of the presentation: Please see How to Give a Presentation Focused on an Experiment to see the goals presenters were asked to address.
   
• Goals of the course: In brief, the primary goal of the course was to bring students into the scientific process of approximating truth, giving due weight to what has been observed, limited by how it was observed, and distinguishing observation from mere assertion. In not brief, see the Course Objectives.
   
• Goals of the review process:
  • Please consider whether the proposal and presentation have addressed the general goals of the course. For example, a generally useful question would be "How do you know that [some assertion] is true?".
     
  • Please consider whether the proposal and presentation have addressed the specific goals of presentations and proposals. For example, if the proposal and presentation does not make abundantly clear that the presenter understands the principle behind the proposed experiment, you might through probing questions give the presenter an opportunity to display (or perhaps discover) such understanding. Do not presume that just because the term "Western blot" rolls confidently off the tongue that the presenter has any idea what it is.
     
  • Presenters are to understand at least one experiment thoroughly, but in doing so, they may not have learned a lot about other experiments. Don't fault them for not having a Plan B.
     
• Feedback: The eight minutes of questioning will by itself provide valuable feedback to the presenter. You're certainly invited to provide written feedback as well if you can, but feel no guilt if you can't. Presenters have until Sunday, May 14, to revise their proposals, if they wish.
   
• Thanks: Please accept them for the bracing experience you've given fledgling molecular biologists.

C. Schedule of Panels

Titles link to the written proposals (active Saturday, May 6, for Panel I and Sunday, May 7, for the other panels).
Presentation links to the corresponding powerpoint presentation (active the day of the presentation).

Panel I: Monday, May 8, 3:00 - 4:00 PM. Harris Hall Room 3112 (see map)
Panelists: John Bigbee, Greg Buck, Pat Trimmer

Alina Afzal	Can Vitamin C prevent the mtDNA in the aged induced pluripotent stem cell? Primary: John Bigbee, Secondary: Pat Trimmer       (Presentation)
Bharath Peddibhotla	Relating the structure of aggregated alpha synuclein in Parkinsonian neurons to its preferential binding on the outer mitochondrial membrane Primary: Pat Trimmer, Secondary: Greg Buck       (Presentation)
EJ Kochis	Differences in GTPase Hydrolysis rates of developmentally regulated rRNAs of Plasmodium Falciparum Primary: Greg Buck, Secondary: Pat Trimmer       (Presentation)
Ruairidh Barlow	Possible Mutation of NDUFA2 Leads to Parkinson's Disease Primary: John Bigbee, Secondary: Greg Buck       (Presentation)

Panel II: Tuesday, May 9, 10:30 - 11:30 AM. Harris Hall Room 3112 (see map)
Panelists: Jeff Dupree, Jennifer Koblinski, Larisa Litovchick

Amanda Luong	Identifying the Protein Interactions Responsible for LIN52 Degradation Primary: Larisa Litovchick, Secondary: Jennifer Koblinski       (Presentation)
Peter Samuel	Citrulline coupled with Arsenic Trioxide as a potential inducer of the PERK/eIF2-alpha apoptotic pathway in GBM cells Primary: Jennifer Koblinski, Secondary: Jeff Dupree       (Presentation)
Neha Sehgal	Activation of the Ryanodine Receptor (UNC-68) and the Success of Neuronal Regeneration Primary: Jeff Dupree, Secondary: Jennifer Koblinski       (Presentation)
Lasya Gundlapudi	Leukocyte Migration through the Blood Brain Barrier       (text version) Primary: Larisa Litovchick, Secondary: Jeff Dupree       (Presentation)

Panel III: Tuesday, May 9, 2:15 - 3:15 PM. Harris Hall Room 3112 (see map)
Panelists: Wan-Ling Chiu, Tony Faber, Andrei Ivanov

Fadi Hijaz	Measurement of Changes in Force Generation of Cardiomyocytes through the Down Regulation of Vinculin using CRISPR-Cas Gene Editing Primary: Andrei Ivanov, Secondary: Tony Faber       (Presentation)
Aarthi Prakash	Furin-Enhanced In Vivo Production of Factor IX Primary: Tony Faber, Secondary: Wan-Ling Chiu       (Presentation)
Neel Gohil	The Role of phospholipase-C beta-1 in intracellular calcium release in smooth muscle contraction Primary: Andrei Ivanov, Secondary: Wan-Ling Chiu       (Presentation)
Alex Leath	Characterization of tRNA Modification Patterns in a Recoded Organism Primary: Wan-Ling Chiu, Secondary: Tony Faber       (Presentation)

Panel IV: Wednesday, May 10, 1:00 - 2:00 PM. Harris Hall Room 3112 (see map)
Panelists: Sarah Rothschild, Rita Shiang, Greg Walsh,

Josh Fung	Tbx5 Dominant Negative Protein Inhibiting Myocardial Regeneration in Zebrafish Primary: Greg Walsh, Secondary: Rita Shiang       (Presentation)
Deeksha Jain	Mutations in MCL-1 PEST Region of Breast Cancer on Binding Affinity to Bak/Bax Primary: Rita Shiang, Secondary: Sarah Rothschild       (Presentation)
Kaivalya Dandamudi	Measurement of the p38 signaling pathway in the Pro253Arg mutation of FGFR2 in regulation of bone development in Apert Syndrome      (original version) Primary: Sarah Rothschild, Secondary: Greg Walsh       (Presentation)

Panel V: Thursday, May 11, 9:30 - 10:30 AM. West Grace South Room 1004a (far northeast side of building; see map)
Panelists: Jane Roberts, Tricia Smith, Stefano Toldo

Ankita Thakur	Treating Ischemia and Reperfusion Injury by Inhibiting AIM2 in order to restore function of Cardiomyocytes Primary: Jane Roberts, Secondary: Stefano Toldo       (Presentation)
Erin Cochran	Cannabinoid receptor interacting protein 1a (CRIP1a) effect on CB1 inverse agonists Primary: Stefano Toldo, Secondary: Tricia Smith       (Presentation)
Jared Mann	Downregulation of Sox2 with CBD via AMPK Primary: Tricia Smith, Secondary: Stefano Toldo       (Presentation)
Danny Rayes	Defining Epidermal Growth Factor Receptor exon 20 mutant sensitivity to tyrosine kinase inhibition Primary: Jane Roberts, Secondary: Tricia Smith       (Presentation)

Panel VI: Thursday, May 11, 11:00 - 12:00 noon. Harris Hall Room 3112 (see map)
Panelists: Gail Christie, Allison Johnson, Peter Uetz

Bethany Yachuw	Antirepressor identification in Bacillus bacteriophage phiCM3 Primary: Allison Johnson, Secondary: Gail Christie       (Presentation)
Jacob Jaminet	Determination of sugar uptake in Saccharomyces Primary: Peter Uetz, Secondary: Allison Johnson       (Presentation)
Nikhita Puthuveetil	The effect of duplication of the variable region stem loops on sfRNA virulence in the dengue virus Primary: Gail Christie, Secondary: Peter Uetz       (Presentation)

Panel VII: Friday, May 12, 9:15 - 10:15 AM. Harris Hall Room 3112 (see map)
Panelists: Bill Barton, Glen Kellogg, Darrell Peterson

Jesse Raynor	Comparison of Exemplars of Rotamer Clusters Across the Proteinogenic Amino Acids Primary: Bill Barton, Secondary: Glen Kellogg       (Presentation)
Thomas Raymond	Determination of Short, Amyloid Beta Derived Peptides Which Inhibit Binding of Amyloid Beta to Apolipoprotein E Primary: Glen Kellogg, Secondary: Darrell Peterson       (Presentation)
Diana Marquez	Implementing CRISPR Type III-B in human cell to target RNA encoded viruses Primary: Darrell Peterson, Secondary: Glen Kellogg       (Presentation)
E Alqaffas	Influenza a, and the process of inhibiting its binding Primary: Bill Barton, Secondary: Darrell Peterson       (Presentation)

Panel VIII: Friday, May 12, 10:30 - 11:30 AM. Harris Hall Room 3112 (see map)
Panelists: Andrew Davies, Javier Maeso, Carmen Sato-Bigbee

Amanda Atrash	Disruption of DISC1 via knockdown of NDEL1 stunts dendritic spine structure in the hippocampus region of mice Primary: Javier Maeso, Secondary: Andrew Davies       (Presentation)
Kevin Limlengco	Elimination of Microglial Cells in Adult Mice using Cre/Lox Recombinase      (original version) Primary: Carmen Sato-Bigbee, Secondary: Andrew Davies       (Presentation)
Teja Katravulapalli	Investigating regulation of aging by transcription factors DAF 16 and SKN-1 in the IIS pathway of C Elegans Primary: Andrew Davies, Secondary: Javier Maeso       (Presentation)
Colin Hawkes	Consequences to the axon initial segment after near total removal of microglia in healthy CNS and in mice suffering recent CNS injury Primary: Carmen Sato-Bigbee, Secondary: Javier Maeso       (Presentation)

Panel IX: Friday, May 12, 11:45 - 12:45 PM. Harris Hall Room 3112 (see map)
Panelists: Jim Lister, Carmen Sato-Bigbee, Fernando Tenjo

Lucas Rizkalla	PDK1 Inhibition and Possible Induction of a Mesenchymal-Epithelial Transition as a Curative Measure in Proliferating Cancer Cells Primary: Fernando Tenjo, Secondary: Jim Lister       (Presentation)
Ryan Duong	Understanding the involvement of NRAP protein in the dystrophin complex of myocytes Primary: Jim Lister, Secondary: Carmen Sato-Bigbee       (Presentation)
Rachel Miller	Blockage of the S1PR1 receptor using S1P modulator Fingolomid on T cells compared to the silencing of MicroRNA miR-155 Primary: Carmen Sato-Bigbee, Secondary: Fernando Tenjo       (Presentation)